Every cancer is unique, so therapies should be too
BlueSphere Bio was founded to enable each patient’s immune system to provide the ability to create their own personal adoptive cell therapy (ACT) to treat their cancer. Our vision is for every cancer patient to have a chance for a cure.
Our novel technology unlocks the potential of individualized T-cell therapy for the treatment of cancer by harnessing the specificity of each patient’s T cells for the unique molecular fingerprint of their own cancer.
MEET OUR TEAM
Board of Directors
Scientific Advisory Board
Director, Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs